Therapy of idiopathic nephrotic syndrome in adults: A conservative or aggressive therapeutic approach?

American Journal of Nephrology

Volumn 13, Issue 5, 1993, Pages 422-428

  Glassock, Richard J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chlorambucil; Cyclophosphamide; Cyclosporine; Focal sclerosis; Glucocorticoids; Membranous glomerulonephritis; Minimal change disease; Nephrotic syndrome

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID;

CONSERVATIVE TREATMENT; FOCAL GLOMERULOSCLEROSIS; HUMAN; IDIOPATHIC DISEASE; KIDNEY FAILURE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ADULT; GLOMERULONEPHRITIS; HUMAN; METHODS; NEPHROTIC SYNDROME;

EID: 0027753930     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168656     Document Type: Article

References (53)

1. Glassock RJ, Adler S, Ward H, Cohen A: Primary glomerular diseases; in Brenner BM, Rector FC (eds): The Kidney. Saunders. Philadelphia, 1991, pp 1182-1279.
2. Lewis E: Management of the nephrotic syndrome in adults; in Cameron JS Glassock RJ (eds): The Nephrotic Syndrome. Dckkcr, New York. 1988, pp 461-521.
3. Cameron JS: The long-term outcome of glomerular diseases: in Schrier RN, Gottschalk CW (eds): Diseases of the Kidney. Little Brown, Boston, 1992, pp 1895-1958.
4. Arneil GC: 164 children with nephrosis. Lancet 1961;ii:1103-1105.
5. Schwartz H, Kohn JL: Lipoid nephrosis. A clinical and pathological study based on fifteen years’ observation with special reference to prognosis. Am J Dis Child 1935;49:579-583.
6. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome: A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979;301:1301-1308.
7. Eddy AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-733.
8. Remuzzi G, Bertani J: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38:384-394.
9. Keane WF, Stein J (eds): Lipids and Renal Disease. Contemporary Issues in Nephrology. New York, Churchill Livingstone 1991, vol 24.
10. Avram M, Klahr S: Lipids and vasoactive agents in renal disease. J Kidney Dis 1992;22:64-237.
11. Bertani J, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
12. Diamond JR: The role of cholesterol in glomerular injury. Lipids and renal disease: in Keane WF, Stein JH (eds): Contemporary Issues in Nephrology, New York, Churchill Livingstone, 1991, pp 109-126.
13. Radhakrishnan J, Appel AS, Valerie A, Appel GB: The nephrotic syndrome, lipids and risk factors for cardiovascular disease. Am J Kidney Dis 1993;22:135-142.
14. Short CD, Durrington PJ, Mallick NP, Hunt LP, Tetlow NP, Ishola M: Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney 1986;29:1224-1228.
15. Broyer M, Meyrier A, Mandet P: Minimal changes and focal segmental glomerulosclerosis; in Cameron JS, Davison AM, Grunfeld JP, Kerr D, Ritz E (eds): Oxford Textbook of Clinical Nephrology. Oxford, Oxford Medical Publishers, 1992, pp 298-338.
16. Shapner HW, Robson AM: Nephrotic syndrome: Minimal change disease, focal glomerulosclerosis and related disorders: in Schrier R. Gottschalk C (eds): Diseases of the Kidney. Little Brown, Boston, 1993, pp 1731-1784.
17. Korbet SM, Schwartz MM, Lewis EJ: Minimal change glomerulopathy of adulthood. Am J Nephrol 1988;8:29.
18. Nolasco F, Cameron JS, Heywood EF, et al: Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 1986;29:1215-1219.
19. Arbeitsgemeinschaft für Pädiatrische Nephrologie: Cyclophosphamide treatment of steroid-dependent nephrotic syndrome: Comparison of 8-week with 12-week course. Arch Dis Child 1987;62:1102-1107.
20. Niaudet P, Broyer M: Cyclosporin in the therapy of idiopathic nephrotic syndrome in children; in Abdreyuai V (ed): International Yearbook of Nephrology. Norwell/Mass, Kluwer Academic Publishers, 1984, pp 155-168.
21. Meyrier A, Simon P: Treatment of corticoresistant idiopathic nephrotic syndrome in the adult. Minimal change disease and focal segmental glomerulosclerosis. Adv Nephrol 1988;17:127-150.
22. British Association for Pediatric Nephrology: Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 1991;337:1555-1558.
23. Cade R, Mars D, Privette M, et al: Effects of long-term azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. Arch Intern Med 1986;146:737-743.
24. Milliner DS, Morganstern BS: Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 1991;5: 587-590.
25. Schreppati A, Mosconi L, Pema A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993,329:85-89.
26. Cameron JS: Membranous nephropathy and its treatment. Nephrol Dial Transplant 1992;7:72-80.
27. Glassock RJ: Secondary membranous glomerulonephritis. Nephrol Dial Transplant 1992;7:64-71.
28. Suki WM, Chavez A: Membranous nephropathy: Response to steroids and immunosuppression. Am J Nephrol 1981;1:11-18.
29. Ponticelli C, Zucchelli P, Passerini P: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989;320:8-13.
30. Schultze M, Donadio J, Pruchno CJ, Baker PJ, Johnson R, Cotiser W: Elevated urinary excretion of the C5B-9 complex in membranous nephropathy. Kidney Int 1991;40:533-538.
31. Mallick NP, Short CD: The nephrotic syndrome and ischemic heart disease. Nephron 1981;27:54-59.
32. Wass V, Cameron JS: Cardiovascular disease and the nephrotic syndrome: The other side of the coin. Nephron 1981;27:58-62.
33. West ML, Jindal KK, Bear RA, Goldstein MD: A controlled trial of cyclophosphamide idiopathic membranous nephropathy. Kidney Int 1987;32:579-584.
34. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Italian Idiopathic Membranous Nephropathy Treatment Study Group: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 1992;327:599-603.
35. Short CD, Solomon LR, Gokal R, Mallick NP: Methylprednisolone in patients with membranous nephropathy and declining renal function. QJ Med 1987;65:929-939.
36. Glassock RJ: The therapy of idiopathic membranous glomerulonephritis. Semin Nephrol 1991;11:138-147.
37. Matheson PW, Turner AN, Maidment CG, Evans DJ, Rees AJ: Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function, lancet 1988;ii:869-872.
38. Falk RJ, Hogan JL, Muller KE, Jennette C, Glomerular Disease Collaborative Network: Treatment of progressive membranous glomerulopathy: A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. Ann Intem Med 1992;116:438-445.
39. De Santo N, Capodicasa G, Giordano C: Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am J Nephrol 1987;7:74-80.
40. Palla R, Cirami C, Panichi V, Bianchi A, Parrim M, Giagi G: Intravenous immunoglobulin therapy of membranous nephropathy. Efficacy and safety. Clin Nephrol 1991;35:98-104.
41. Cattran DC and the Canadian Glomerulonephritis Research Group: Cyclosporine in treatment of membranous nephropathy (abstract). Proc XIIth Int Congr Nephrology. Jerusalem 1993, p 535.
42. Garcia D, Rennke H, Brenner B, Anderson S: Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest 1987;80:867-874.
43. Velosa JA, Holley KE, Torres VE, Offord KP: Significance of proteinuria in the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 1983;58:568-573.
44. Pei Y, Cattran D, Delmore T, et al: Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 1987;82:938-946.
45. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F: Recurrent focal sclerosis: Natural history and response to therapv. Am J Med 1992;92:375-383.
46. Howie AJ: Changes at the glomerular tip: A feature of membranous nephropathy and other diseases associated with proteinuria. J Pathol 1986;150:13-17.
47. Howie AJ, Brewer DB: Further studies in the glomerular tip lesion: Early and late stages and life table analysis. J Pathol 1985;147:245-249.
48. Waldherr R, Gubler MC, Levy M, et al: The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol 1978;10:171-176.
49. Griswold WR, Tune BM, Reznik VM, et al: Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron 1987:46:73-77.
50. Banfi G, Moriggi M, Sabadini E, Fellini G, D’Amico G, Ponticelli C: The impact of prolonged immunosuppression on the outcome of idiopathic focal and segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective studv. Clin Nephrol 1991;36:53-59.
51. Niaudet P, Broyer M, Habib L: Treatment of childhood idiopathic nephrotic syndrome with cyclosporine (abstract). Proc XIIth Int Congr Nephrology. Jerusalem 1993, p 534.
52. Melocotow T, Kamel E, Cohen A, Fine L: Long-term cyclosporine A in the treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991;18:583-588.
53. Meyrier A, Condamen MC, Broneer D, Collaborative Group of the French Society of Nephrology: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal change disease and focal and segmental glomerulosclerosis. Clin Nephrol 1991;35:37-42.